Categories AlphaGraphs, Earnings, Technology

Qualcomm shares rise after earnings beat estimates

Qualcomm shares rose around 2% in the aftermarket after it reported better-than-expected earnings results in the second quarter of 2018. Revenue for the quarter witnessed a modest growth of 5% to $5.3 billion.

Meanwhile, earnings took a hit during the quarter due to its legal tussle with Apple (AAPL) over the alleged unfair licensing practice. GAAP EPS fell 52% to $0.24 per share, while on an adjusted basis, earnings came in at $0.80 per share, down 40% year-over-basis.

The company did not record QTL revenues during the quarter, for royalties due on the sale of Apple’s or the other licensee’s products.

 

Qualcomm Q2 2018 Earnings

 

 

Qualcomm, which escaped a hostile takeover bid by Broadcom (AVGO), has been going through a rough phase for the past few years. Apart from its ongoing battle with Apple, Qualcomm was crushed by the trade war between China and the US.

Qualcomm may have a lot to lose in the brewing trade war as it is banned from selling its semiconductors to ZTE Corp. — a Chinese telecom equipment maker. This ban will have a severe impact the company’s revenue.

Due to these political struggles, the company’s deal with NXP Semiconductors (NXPI) is getting delayed. Qualcomm is said to refile an application with the Chinese regulators seeking clearance for its proposed $44 billion takeover of NXP Semiconductors. The two companies earlier pushed the closure date to July of this year.

Meanwhile, Qualcomm is ramping up its operations to boost its earnings. It rolled out a $1 billion cost-cutting plan early this year and is considering layoffs to boost long-term growth.

The company forecasts revenue for the full year to be around $4.8 billion to $5.6 billion, with EPS of $0.35 to $0.50.

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top